These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34339849)

  • 21. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome.
    Moss AJ; Zareba W; Hall WJ; Schwartz PJ; Crampton RS; Benhorin J; Vincent GM; Locati EH; Priori SG; Napolitano C; Medina A; Zhang L; Robinson JL; Timothy K; Towbin JA; Andrews ML
    Circulation; 2000 Feb; 101(6):616-23. PubMed ID: 10673253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. β-Blocker Adherence in Familial Long QT Syndrome.
    Waddell-Smith KE; Li J; Smith W; Crawford J; Skinner JR;
    Circ Arrhythm Electrophysiol; 2016 Aug; 9(8):. PubMed ID: 27516460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of oral contraceptive progestins on serum copper concentration.
    Berg G; Kohlmeier L; Brenner H
    Eur J Clin Nutr; 1998 Oct; 52(10):711-5. PubMed ID: 9805216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals.
    Goldenberg I; Horr S; Moss AJ; Lopes CM; Barsheshet A; McNitt S; Zareba W; Andrews ML; Robinson JL; Locati EH; Ackerman MJ; Benhorin J; Kaufman ES; Napolitano C; Platonov PG; Priori SG; Qi M; Schwartz PJ; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Zhang L
    J Am Coll Cardiol; 2011 Jan; 57(1):51-9. PubMed ID: 21185501
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intentional nontherapy in long QT syndrome.
    MacIntyre CJ; Rohatgi RK; Sugrue AM; Bos JM; Ackerman MJ
    Heart Rhythm; 2020 Jul; 17(7):1147-1150. PubMed ID: 32105774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A high-risk patient with long-QT syndrome with no response to cardioselective beta-blockers.
    Toyota N; Miyazaki A; Sakaguchi H; Shimizu W; Ohuchi H
    Heart Vessels; 2015 Sep; 30(5):687-91. PubMed ID: 25028166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association Between Syncope Trigger Type and Risk of Subsequent Life-Threatening Events in Patients With Long QT Syndrome.
    Younis A; Bos JM; Zareba W; Aktas MK; Wilde AAM; Tabaja C; Bodurian C; Tobert KE; McNitt S; Polonsky B; Shimizu W; Ackerman MJ; Goldenberg I
    JAMA Cardiol; 2023 Aug; 8(8):775-783. PubMed ID: 37436769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Do patients with long QT syndrome remain at risk for sudden cardiac death after 40 years of age?
    Postema PG; Wilde AA
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):602-3. PubMed ID: 18665134
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long QT syndrome in African-Americans.
    Fugate T; Moss AJ; Jons C; McNitt S; Mullally J; Ouellet G; Goldenberg I; Zareba W; Robinson JL;
    Ann Noninvasive Electrocardiol; 2010 Jan; 15(1):73-6. PubMed ID: 20146785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk of cardiac events in patients with asthma and long-QT syndrome treated with beta(2) agonists.
    Thottathil P; Acharya J; Moss AJ; Jons C; McNitt S; Goldenberg I; Zareba W; Kaufman E; Qi M; Robinson JL;
    Am J Cardiol; 2008 Oct; 102(7):871-4. PubMed ID: 18805113
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and molecular genetic risk determinants in adult long QT syndrome type 1 and 2 patients : Koponen et al. Follow-up of adult LQTS patients.
    Koponen M; Havulinna AS; Marjamaa A; Tuiskula AM; Salomaa V; Laitinen-Forsblom PJ; Piippo K; Toivonen L; Kontula K; Viitasalo M; Swan H
    BMC Med Genet; 2018 Apr; 19(1):56. PubMed ID: 29622001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genotype-specific risk stratification and management of patients with long QT syndrome.
    Barsheshet A; Dotsenko O; Goldenberg I
    Ann Noninvasive Electrocardiol; 2013 Nov; 18(6):499-509. PubMed ID: 24206565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical aspects of the three major genetic forms of long QT syndrome (LQT1, LQT2, LQT3).
    Kutyifa V; Daimee UA; McNitt S; Polonsky B; Lowenstein C; Cutter K; Lopes C; Zareba W; Moss AJ
    Ann Noninvasive Electrocardiol; 2018 May; 23(3):e12537. PubMed ID: 29504689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genotype-specific QT correction for heart rate and the risk of life-threatening cardiac events in adolescents with congenital long-QT syndrome.
    Barsheshet A; Peterson DR; Moss AJ; Schwartz PJ; Kaufman ES; McNitt S; Polonsky S; Buber J; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Towbin JA; Vincent GM; Zhang L; Goldenberg I
    Heart Rhythm; 2011 Aug; 8(8):1207-13. PubMed ID: 21397043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
    ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
    Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long QT Syndrome Management during and after Pregnancy.
    Marcinkeviciene A; Rinkuniene D; Puodziukynas A
    Medicina (Kaunas); 2022 Nov; 58(11):. PubMed ID: 36422233
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Type 3 long QT syndrome: Is the effectiveness of treatment with beta-blockers population-specific?
    Hermida A; Gourraud JB; Denjoy I; Fressart V; Kyndt F; Maltret A; Khraiche D; Klug D; Mabo P; Sacher F; Maury P; Winum P; Defaye P; Clerici G; Babuty D; Elbez Y; Morgat C; Surget E; Messali A; De Jode P; Clédel A; Minois D; Maison-Blanche P; Bloch A; Leenhardt A; Probst V; Extramiana F
    Heart Rhythm; 2024 Mar; 21(3):313-320. PubMed ID: 37956775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene-specific effect of beta-adrenergic blockade on corrected QT interval in the long QT syndrome.
    Extramiana F; Maison-Blanche P; Denjoy I; De Jode P; Messali A; Labbé JP; Leenhardt A
    Ann Noninvasive Electrocardiol; 2013 Jul; 18(4):399-408. PubMed ID: 23879280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk of syncope in family members who are genotype-negative for a family-associated long-QT syndrome mutation.
    Barsheshet A; Moss AJ; McNitt S; Polonsky S; Lopes CM; Zareba W; Robinson JL; Ackerman MJ; Benhorin J; Kaufman ES; Towbin JA; Vincent GM; Qi M; Goldenberg I
    Circ Cardiovasc Genet; 2011 Oct; 4(5):491-9. PubMed ID: 21831960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trigger-specific risk factors and response to therapy in long QT syndrome type 2.
    Kim JA; Lopes CM; Moss AJ; McNitt S; Barsheshet A; Robinson JL; Zareba W; Ackerman MJ; Kaufman ES; Towbin JA; Vincent M; Goldenberg I
    Heart Rhythm; 2010 Dec; 7(12):1797-805. PubMed ID: 20850565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.